Pharmaceutical Industry

The State of the External Attack Surface

Discover the most common vulnerabilities and top risk exposures

Pharmaceutical Industry

The State of the External Attack Surface

Discover the most common vulnerabilities and top risk exposures

Share:

Share on linkedin
Share on facebook
Share on twitter

What’s inside?

This report examines the security posture of the pharmaceutical industry while delivering unique insights into external attack surface exposures and security issues that pharmaceutical companies are currently experiencing.

Read this to learn about:

  1. Most commonly exposed services in pharmaceutical companies’ external attack surface
  2. The most prevalent critical security issues discovered
  3. How to reduce unknown exposures and IT security risks

The data in this report was derived from Reposify’s External Attack Surface Management platform during March 2021. The report presents information about exposure of services and cybersecurity risks, which are prevalent among leading pharmaceutical companies and their 600+ subsidiaries worldwide.

Read Next

Read how CISOs and cybersecurity teams can safeguard their digital perimeter using EASM at every stage of their cloud journey.
Quis custodiet ipsos custodes? We analyzed the security posture of 35 cybersecurity firms, and their 350+ subsidiaries. Download now for groundbreaking insights.
Read this guide to learn about the risks resulting from unknown assets and discover the new way to safeguard your perimeter-less network.